შპს ბიომედიკა

Ratio	2018	2019	2020	2021	2022	2023	2024
Margins
Gross Margin	41.1%	42.3%	43.8%	43.1%	54.1%	63.9%	57.2%
EBITDA Margin	10.1%	19.5%	18.4%	21.9%	37.7%	35.5%	32.7%
EBITDAR	338	739	707	917	2,059	2,356	2,250
EBITDAR Margin	10.1%	21.6%	21.1%	24.3%	39.2%	35.9%	34.2%
EBIT Margin	10.1%	18.8%	17.9%	21.5%	37.5%	35.3%	32.5%
Net Profit Margin	9.4%	18.8%	28.5%	17.0%	12.1%	35.5%	32.7%
Operating Expense % of Sales	31.0%	22.8%	25.5%	21.2%	16.4%	28.4%	24.5%
Returns
Return on Assets (ROA)	18.7%	25.1%	28.6%	20.8%	17.4%	39.4%	25.7%
Return on Equity (ROE)	32.0%	43.5%	41.5%	21.8%	17.7%	39.4%	26.7%
ROIC [EBIT / Invested Capital]	75.0%	84.2%	27.5%	37.9%	98.8%	45.7%	57.6%
Leverage & debt balances
Debt-to-Assets	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Debt-to-Equity	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Debt-to-EBITDA	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x	0.00x
Equity-to-Assets	58.5%	57.7%	68.7%	95.3%	98.3%	100.0%	95.9%
Net Debt	-528	-713	-122	-800	-1,587	-848	-4,350
Cash & Equivalents	528	713	122	800	1,587	848	4,350
Total Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Liquidity & working capital
Current Ratio	2.25x	2.27x	2.36x	16.78x	56.70x	N/A	N/A
Quick Ratio	2.25x	0.99x	0.00x	16.78x	56.70x	N/A	N/A
Cash Ratio	0.76x	0.66x	0.12x	5.45x	25.66x	N/A	N/A
Total Current Assets	1,564	2,454	2,467	2,462	3,506	1,535	6,282
Total Current Liabilities	695	1,083	1,048	147	62	N/A	N/A
Inventory	N/A	1,378	2,467	N/A	N/A	N/A	N/A
Trade Receivables	321	363	654	681	1,168	600	1,983
Trade Payables	691	1,075	1,044	147	62	N/A	340
Net Working Capital	869	1,371	1,420	2,315	3,444	1,535	6,282
Net Working Capital % of Revenue	26.0%	40.1%	42.3%	61.4%	65.5%	23.4%	95.4%
Trade Working Capital	-371	666	2,077	534	1,105	600	1,643
Trade Working Capital % of Revenue	-11.1%	19.5%	61.9%	14.2%	21.0%	9.2%	25.0%
Change in Trade Working Capital	N/A	1,037	1,411	-1,542	571	-505	1,043
Turnover & efficiency
Inventory Turnover	N/A	1.43x	0.76x	N/A	N/A	N/A	N/A
Days Inventory Outstanding (DIO)	N/A	254.9	477.8	N/A	N/A	N/A	N/A
Receivables Turnover	10.44x	9.41x	5.13x	5.54x	4.50x	10.93x	3.32x
Days Sales Outstanding (DSO)	34.9	38.8	71.1	65.9	81.1	33.4	110.0
Payables Turnover	2.85x	1.84x	1.81x	14.62x	38.61x	N/A	8.27x
Days Payable Outstanding (DPO)	128.0	198.8	202.2	25.0	9.5	N/A	44.1
Cash Conversion Cycle	-93.0 days	94.8 days	346.7 days	41.0 days	71.7 days	33.4 days	65.8 days
Asset Turnover	2.00x	1.33x	1.00x	1.22x	1.44x	1.11x	0.78x
Cash flow & dividends
Operating Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow (OCF − Capex proxy)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Conversion (OCF / EBITDA)	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividends Declared	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend Payout Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in ₾ '000. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.

Ownership & group structure

Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.

companyinfo.ge · fetched 2026-07-15

Shareholders

ბესიკ შამუგია100.0%

ბესიკ შამუგიაPartner / Shareholder100.0%

Directors & board

ბესიკ შამუგიაDirector

Ownership & directors from companyinfo.ge (public corporate registry).